<DOC>
	<DOCNO>NCT02470767</DOCNO>
	<brief_summary>describe sociodemographic clinical characteristic patient diagnose non-valvular atrial fibrillation ( NVAF ) risk stroke systemic embolism anticoagulant therapy change therapeutic regimen , due clinical situation , base doctor 's routine clinical practice currently treatment direct oral anticoagulant ( DOAC )</brief_summary>
	<brief_title>An Observational Cross-sectional Study Evaluating Sociodemographic Clinical Characteristics Patients Diagnosed With NVAF With Risk Stroke Systemic Embolism , Who Are Treatment Adequately Control Their Coagulation Treated Primary Care Centres</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Patients â‰¥18 year age diagnose NVAF risk stroke systemic embolism treat primary care centre . Patients regular treatment anticoagulant change therapeutic regimen due clinical situation treatment DOAC least three month recruit ( date signing informed consent ) . Patients whose DOAC indicate primary care physician . Patients give informed consent writing . Patients change anticoagulant therapy within period le three month sign informed consent . Patients cognitive impairment prevent understanding write patient information sheet informed consent , perform selfadministered questionnaire . Patients start anticoagulant therapy NVAF DOAC .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>